SCHEMBL4480084

SCHEMBL4480084

Cc1ccc(Cl)cc1-c1ccc(CN2CC(C)OC(C)C2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.56
TDP1 Q9NUW8 1/20 0.56
AGTR1 P30556 1/20 0.49
AGTR2 P50052 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.48
LMNA P02545 2/20 0.46
NPC1 O15118 1/20 0.46
ALDH1A1 P00352 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HTT P42858 1/20 0.45
POLB P06746 2/20 0.43
HRH4 Q9H3N8 1/20 0.43
HRH3 Q9Y5N1 1/20 0.43
CYP2A13 Q16696 1/20 0.43
GRM2 Q14416 2/20 0.42
PDE1B Q01064 1/20 0.41
S1PR1 P21453 2/20 0.41
S1PR5 Q9H228 2/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4480082 1.00 KDM4E (0.56) KDM4ETDP1AGTR1AGTR2L3MBTL1
SCHEMBL4472255 0.88 KDM4E (0.60) KDM4ETDP1AGTR1AGTR2L3MBTL1
SCHEMBL4489047 0.88 AGTR1 (0.50) KDM4ETDP1AGTR1AGTR2L3MBTL1
SCHEMBL4465612 0.78 HRH3 (0.59) KDM4ELMNANPC1ALDH1A1RAB9A
SCHEMBL4470243 0.77 KDM4E (0.62) KDM4ETDP1AGTR1AGTR2L3MBTL1
SCHEMBL4470239 0.77 KDM4E (0.62) KDM4ETDP1AGTR1AGTR2L3MBTL1
SCHEMBL12383 0.75 ALDH1A1 (0.55) KDM4ETDP1AGTR1AGTR2LMNA
SCHEMBL3744757 0.74 KDM4E (0.53) KDM4ETDP1AGTR1AGTR2L3MBTL1
SCHEMBL17724134 0.73 PDE1B (0.46) KDM4ETDP1AGTR1AGTR2LMNA
SCHEMBL17724136 0.73 PDE1B (0.56) KDM4ETDP1AGTR1AGTR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7595397-B2 Compounds which modulate the CB2 receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-09-29 US disclosed
US-7595397-B2 Compounds which modulate the CB2 receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-09-29 US disclosed
US-7595397-B2 Compounds which modulate the CB2 receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-09-29 US disclosed
EP-1966132-A2 COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-09-10 EP disclosed
US-20070191340-A1 Compounds Which Modulate The CB2 Receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-08-16 US disclosed
US-20070191340-A1 Compounds Which Modulate The CB2 Receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-08-16 US disclosed
US-20070191340-A1 Compounds Which Modulate The CB2 Receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-08-16 US disclosed
WO-2007070760-A2 COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-06-21 WO disclosed
WO-2007070760-A2 COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-06-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191340-A1 Compounds Which Modulate The CB2 Receptor CNR1, CNR2, ARRB1 KDM4E 2472/4885TDP1 4624/4885AGTR1 234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.